Oxford jabs effective against severe Covid: US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......

COPD: 2nd biggest cause for deaths in India

'COPD causes an economic loss of Rs 35,000 crores.''We cannot afford to lose such a huge amount due to one disease.''COPD is a non-communicable disease and that's why it remained low in......

'Arthur could tell Hrithik, Kajol they made him feel old...'

'...because he had interviewed their grandparents in their heyday.' P Rajendran looks back on the 11 plus years he worked with Arthur J Pais, the India Abroad and Rediff.com editor, who passed into......

As 'America's Doctor,' Vivek Murthy will hit the ground running

More than a year after he was nominated by President Barack Obama, the US Senate, defying the powerful pro-gun lobby National Rifle Association, voted to confirm Dr Vivek Hellegere Murthy as the......

'New breed' Indian Diaspora has its heart in the right place

Indians all over the US are going beyond being human and are learning to be humanitarian and expand their philanthropy activities finds Ajailiu Niumai. 'The raising of extraordinarily large sums of......

It's a tough road ahead for pharma companies

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny. These companies need to ensure that not only their own quality and standards improve but also......

Growth will be back on track by elections: Chidambaram

'India will succeed. I know this past year has caused a lot of concern, but this year is over and by elections we will achieve our ambitious economic agenda.' Aziz Haniffa on P Chidambaram's......

Merck moves HC against Glenmark

In yet another legal battle between a multinational company and domestic drug manufacturing firms, Merck Sharp and Dohme has moved the Delhi High Court against Mumbai-based Glenmark......